Tenderwize
Back to tender search

Open-house biologics rebate agreement for Natalizumab (subcutaneous formulation)

Techniker Krankenkasse·Hamburg, Germany·Deadline Jan 30, 2028 · 529 days left·Open·Supplies
Sign up to saveOpen documents
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-36 - Natalizumab (Darreichungsform zur subkutanen Injektion)

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature or by...

Participation is limited to pharmaceutical undertakings for the relevant medicinal product and requires valid authorisa...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Conclusion of pharmaceutical rebate agreements for Natalizumab (subcutaneous injection formulation).
  • Open-house arrangement with uniform contractual conditions and no individual negotiations.
Show full summary

Open-house pharmaceutical supply arrangement for Natalizumab (subcutaneous formulation) in Germany, led by Techniker Krankenkasse with HEK and hkk as participating buyers. The notice states that any suitable pharmaceutical undertaking may join during the contract period, with no exclusivity and no individual negotiations. The contract runs for up to 24 months from 01.02.2026 and ends no later than 31.01.2028. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the documents are only available electronically. No contract value is stated.

Risks

Contracts cannot be submitted through the portal; they must be sent by email with qualified electronic signature or by...

Participation is limited to pharmaceutical undertakings for the relevant medicinal product and requires valid authorisa...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the offered medicinal product(s).
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product(s), or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for Natalizumab (subcutaneous formulation)

Single lot covering the conclusion of pharmaceutical rebate agreements under Section 130a(8) SGB V for Natalizumab in subcutaneous formulation. Scope is nationwide in Germany. The notice says the arrangement is open-house, with uniform terms, no exclusivity, and no individual negotiations. Lot information is taken from structured data and the notice text.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 30, 2028

Procurement Details

Publication date
23 Nov 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
776899-2025

Documents (1)

Procurement document 1

Similar tenders

Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)

Sep 15
1 SME lot

Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów

Sep 17

France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord

Sep 14
6 SME lots

Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)

Aug 27
3 framework lots3 SME lots

Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ

Sep 18

Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).

Sep 24